TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is
pioneering the use of robotics to improve minimally invasive surgery,
will ring The Opening Bell® of the New York Stock
Exchange (NYSE) on Wednesday, September 23, 2015 to celebrate the
recently closed acquisition of the surgical robotic division of SOFAR
S.p.A. TransEnterix has been a NYSE MKT listed company since April 2014.
"TransEnterix is proud to ring the opening bell on behalf of our entire
team and investors in celebration of our recently completed acquisition
of SOFAR’s surgical robotic division. This transaction supports our
vision of transforming robotic surgery for patients, surgeons and
hospitals," said Todd M. Pope, President and CEO of TransEnterix. "These
are exciting times at TransEnterix, and we look forward to continuing on
our journey with the NYSE."
Mr. Pope will be joined by Andrea Biffi, CEO of SOFAR and a member of
the TransEnterix Board of Directors, along with several other members of
the TransEnterix and SOFAR management teams as he rings the opening bell
at 9:30am EST on September 23, 2015. A live feed of the NYSE Opening
Bell (9:26 a.m. ET) can be found at www.livestream.com/NYSE.
Photos and video of the NYSE Bell Ringing Ceremony will also be
available, courtesy of the NYSE, on Facebook (NYSE),
Twitter (@NYSE and @NYSECam),
and YouTube (nysetv1).
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of
robotics to improve minimally invasive surgery by addressing the
clinical and economic challenges associated with current laparoscopic
and robotic options. The company is focused on the development and
commercialization of the SurgiBot™ System, a single-port, robotically
enhanced laparoscopic surgical platform, and the commercialization of
ALF-X®, a multi-port robotic system that brings the
advantages of robotic surgery to patients while enabling surgeons with
innovative technology such as haptic feedback and eye tracking camera
control. The SurgiBot System is not yet available for sale in any
market. The ALF-X has been granted a CE Mark but is not available for
sale in the US. For more information, visit the TransEnterix website at www.transenterix.com.
Forward-Looking Statements
This press release includes statements relating to TransEnterix’s
recent acquisition of SOFAR S.p.A’s. surgical robotics division. These
statements and other statements regarding our future plans and goals
constitute "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, and are intended to qualify for the safe harbor
from liability established by the Private Securities Litigation Reform
Act of 1995. Such statements are subject to risks and uncertainties that
are often difficult to predict, are beyond our control, and which may
cause results to differ materially from expectations. Factors that could
cause our results to differ materially from those described include, but
are not limited to, whether our acquisition of the ALF-X surgical
robotics system will be successful, whether the combination of the
SurgiBot and ALF-X supports our vision of transforming robotic surgery
for patients, surgeons and hospitals; whether SurgiBot System's 510(k)
application(s) submitted on June 1, 2015 will be cleared by the U.S.
FDA, whether we will be able to efficiently and successfully integrate
the acquisition into our operations, the pace of adoption of our
products by surgeons, the success and market opportunity of our
products, the effect on our business of existing and new regulatory
requirements and other economic and competitive factors. For a
discussion of the most significant risks and uncertainties associated
with TransEnterix's business, please review our filings with the
Securities and Exchange Commission (SEC), including our Quarterly Report
on Form 10-Q filed on August 6, 2015 and other filings we make with the
SEC. You are cautioned not to place undue reliance on these forward
looking statements, which are based on our expectations as of the date
of this press release and speak only as of the origination date of this
press release. We undertake no obligation to publicly update or revise
any forward-looking statement, whether as a result of new information,
future events or otherwise.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150922005473/en/
Copyright Business Wire 2015